ATAI
AtaiBeckleyDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
The post-earnings company update kept the core bull thesis intact: BPL-003 Phase 3 is still slated for Q2 2026, VLS-01 topline is still expected in Q4 2026, and management says the balance sheet funds the company into 2029 [#8-K-2026-05-12] [#10-Q-2026-05-12]. A secondary post-print signal also appears constructive, with StockAnalysis surfacing a Canaccord target increase to $15 from $14 after the release.
Posture
Defensive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +34.6.
What can break
Clinical-stage concentration risk is high: BPL-003 is the lead value driver, while VLS-01 and EMP-01 remain developmental and subject to trial-readout volatility.
Momentum
94
Value
41
Sentiment
19
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.50 · Bull $8.00 · Bear $2.50
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-17 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-14 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $11.95
Why
Momentum94 · Δ7d +34.6
Value41 · Δ7d -0.1
Sentiment19 · Δ7d -31.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Momentum · See technicals
Momentum
94
26% active weight
Current posture
7d trendSoftening
Δ7d
+34.6
Δ21d
+53.6
Value
41
39% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
0.0
Sentiment
19
34% active weight
Current posture
7d trendSoftening
Δ7d
-31.1
Δ21d
-27.4
Why this grade
Composite grade D. Momentum 94.5 / Value 41.1 / Sentiment 19.0
Fundamentals (TTM)As of 2026-07-17
Fundamentals (TTM)
As of 2026-07-17
Market Cap
$2.66B
Beta
1.62
Shares Out
368.17M
P/E (TTM) · Derived
-2.5
P/S (TTM)
464.95
P/FCF (TTM) · Derived
-17.78
Rev YoY
-38.6%
EPS YoY
-44.4%
Gross Margin
-5.4%
Op Margin
-3272.5%
Net Debt
-$253.97M
Current Ratio
10.02
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology